koryu

editas medicine crispr/cas9 investment

לונג
koryu מעודכן   
NASDAQ:EDIT   Editas Medicine, Inc.
12
I enter long as long term investment in CRISPR/Cas9 technology.

There is still a patent battle going on, thats why there is the big dump in the chart.

Buying here feels like catching the knife, so buying slowly over time.


עסקה פעילה:
nice start. also watching NTLA
הערה:
was lucky and got in at 13.40$

There was a bullish divergence on daily rsi. Now watching carefully if it is an additional inv h+s forming. Really like this stock. Ready to increase position if bottom is confirmed.

הערה:
increasing position in this dip
הערה:
pitchfork scenario
הערה:
adjusted pitchfork and channel, fits really good! would be amazing bull market (must break out the channel!) definitly watch this
הערה:
break out channel and horizontal resistance! <3
הערה:
EW
הערה:
bounced on the potential pitchfork and formed a weekly hammer candle which tested the long term downtrend in bullish manner
הערה:
HODL the double up :D

כתב ויתור

המידע והפרסומים אינם אמורים להיות, ואינם מהווים, עצות פיננסיות, השקעות, מסחר או סוגים אחרים של עצות או המלצות שסופקו או מאושרים על ידי TradingView. קרא עוד בתנאים וההגבלות.